Business Description
ISIN : US62548M2098
Share Class Description:
CTEV: Ordinary Shares - Class ATotal Employee Number:
3,000Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -0.06 | |||||
Debt-to-Equity | -15.93 | |||||
Debt-to-EBITDA | 9.8 | |||||
Interest Coverage | 0.29 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.44 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.6 | |||||
3-Year EBITDA Growth Rate | 42.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.97 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.19 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 72.97 | |||||
9-Day RSI | 67.57 | |||||
14-Day RSI | 64.62 | |||||
3-1 Month Momentum % | -7.7 | |||||
6-1 Month Momentum % | 68.3 | |||||
12-1 Month Momentum % | -68.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.06 | |||||
Days Sales Outstanding | 47.7 | |||||
Days Payable | 58.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | -11.98 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.29 | |||||
Operating Margin % | 11.57 | |||||
Net Margin % | -28.46 | |||||
EBITDA Margin % | 48.12 | |||||
FCF Margin % | -1.8 | |||||
OCF Margin % | 13.37 | |||||
ROA % | -5.77 | |||||
ROIC % | 1.86 | |||||
3-Year ROIIC % | 11.84 | |||||
ROC (Joel Greenblatt) % | 8.69 | |||||
ROCE % | 0.66 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 7 | |||||
PE Ratio without NRI | 40.4 | |||||
PS Ratio | 0.66 | |||||
Price-to-Operating-Cash-Flow | 4.96 | |||||
EV-to-EBIT | 173.83 | |||||
EV-to-EBITDA | 11.18 | |||||
EV-to-Forward-EBITDA | 10.55 | |||||
EV-to-Revenue | 5.38 | |||||
EV-to-Forward-Revenue | 5.29 | |||||
EV-to-FCF | -298.58 | |||||
Price-to-GF-Value | 1.38 | |||||
Price-to-Projected-FCF | 0.7 | |||||
Earnings Yield (Greenblatt) % | 0.58 | |||||
FCF Yield % | -2.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CTEV
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Claritev Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 994.669 | ||
| EPS (TTM) ($) | -17.01 | ||
| Beta | 0.5315 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.15 | ||
| Volatility % | 132.73 | ||
| 14-Day RSI | 64.62 | ||
| 14-Day ATR ($) | 2.718004 | ||
| 20-Day SMA ($) | 34.4295 | ||
| 12-1 Month Momentum % | -68.2 | ||
| 52-Week Range ($) | 11.5 - 74.0699 | ||
| Shares Outstanding (Mil) | 16.95 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Claritev Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Claritev Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-26 | In 180 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-23 16:30 | In 178 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-23 | In 177 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 69 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 68 days | ||
| Morgan Stanley 24th Annual Global Healthcare Conference | 2026-09-15 09:15 | In 17 days | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-11 10:00 | 34.07 (+2.47%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:00 | 26.84 (+3.59%) | ||
| Second quarter earnings results for 2026 | 2026-08-07 | 26.84 (+3.59%) | ||
| Truist Securities Healthcare Disruptors & Digital Health Conference | 2026-06-24 13:00 | 30.06 (+4.63%) |
Claritev Corp Frequently Asked Questions
Guru Commentaries on NYSE:CTEV
Claritev was a significant winner for us last year but more recently has come under pressure due to concerns surrounding AI. Claritev is a source of third-party pricing information for insurance companies that need to reimburse out-of-network healthcare providers. The company is also seeking to monetize its extensive pricing and healthcare data trove by providing this information to healthcare providers and corporations that are selecting plans. We believe that Claritev, with its petabytes of data, is on the 'right side' of AI and will benefit from rather than be displaced by AI, but we expect it will take a few quarters to prove out.
Claritev was a significant winner for us last year but more recently has come under pressure due to concerns surrounding AI. Claritev is a source of third-party pricing information for insurance companies that need to reimburse out-of-network healthcare providers. The company is also seeking to monetize its extensive pricing and healthcare data trove by providing this information to healthcare providers and corporations that are selecting plans. We believe that Claritev, with its petabytes of data, is on the 'right side' of AI and will benefit from rather than be displaced by AI, but we expect it will take a few quarters to prove out.
Press Release
Articles on Claritev Corp
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
